ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer.

N Pompas-Veganzones et al.PubMed ↗Publisher ↗

No numbers read from the abstract.